Syntimmune has appointed Jean-Paul Kress as president and CEO. Source: BioSpace

The new 7600 square feet custom-built, state-of-the-art facility hosts Denovo's biomarker discovery platform, US clinical team and serves as Denovo's US headquarters. Source: BioSpace

BlueRock Therapeutics, which has locations in Toronto, NYC and Cambridge, Mass., rocketed to existence in December 2016 with $225M in venture funding to focus on regenerative medicine, using iPSC therapies.…

The round was co-led by 5AM Ventures, Kleiner Perkins, Novartis Venture Fund, and Sanofi Ventures. Source: BioSpace

The annual Hotbed Maps have guided professionals in their career paths all across the country and abroad. Source: BioSpace

The funds will be used to expand its growing pipeline and progress several early stage molecules towards the clinic. Source: BioSpace

Sangamo and Pfizer will use the company's ZFP-TFs to develop the treatments that are linked to mutations of the C9ORF72 gene, which can cause both ALS and FTLD. Source: BioSpace

In conjunction with the financing, Tony Yao, MD, PhD, a Partner at ArrowMark Partners, will join NexImmune’s Board of Directors. Source: BioSpace

BioSpace is proud to present its NextGen "Class of 2018," a list of 20 up-and-coming life science companies in North America that started up no earlier than 2016. Source: BioSpace

Werner Cautreels, Ph.D., intends to retire effective December 31, 2018. Source: BioSpace